- The shares of Ambev (NYSE: ABEV) have received a price target of $3.50. These are the details.
The shares of Ambev (NYSE: ABEV) have received a price target of $3.50 from Barclays. And Barclays analyst Benjamin Theurer upgraded Ambev to “Overweight” from “Equal Weight” while reducing the price target from $4.
Theurer noted that the ongoing improvements in AmBev’s innovation strategy and a moderate mix improvement between price and volume should increase its financial results in 2022 and beyond. And while Theurer sees continued raw material cost pressure in 2022, he modeled less pressure than this year.
Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.